(Q37782561)

23 August 2017

0 references

Locally-administered intrathecal thrombolytics following aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis (English)

1 reference

23 August 2017

Locally-administered Intrathecal Thrombolytics Following Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-analysis (English)

1 reference

https://api.crossref.org/works/10.1007/S12028-010-9429-Z

23 June 2024

1 reference

1 reference

aneurysmal subarachnoid hemorrhage

1 reference

1 reference

Andreas H. Kramer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20740327

23 June 2024

Jeffrey J. Fletcher

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20740327

23 June 2024

language of work or name

1 reference

1 June 2011

1 reference

full work available at URL

23 August 2017

http://link.springer.com/content/pdf/10.1007/s12028-010-9429-z.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1007/S12028-010-9429-Z

http://link.springer.com/article/10.1007/s12028-010-9429-z/fulltext.html

23 June 2024

1 reference

https://api.crossref.org/works/10.1007/S12028-010-9429-Z

http://link.springer.com/content/pdf/10.1007/s12028-010-9429-z

23 June 2024

1 reference

https://api.crossref.org/works/10.1007/S12028-010-9429-Z

23 June 2024

1 reference

23 August 2017

volume

14

1 reference

23 August 2017

issue

3

1 reference

23 August 2017

page(s)

489-499

1 reference

Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12028-010-9429-Z

Global and domain-specific cognitive impairment and outcome after subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-010-9429-Z

Prognostic factors for outcome in patients with aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-010-9429-Z

Factors associated with hydrocephalus after aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-010-9429-Z

Factors associated with the development of vasospasm after planned surgical treatment of aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-010-9429-Z

Clot volume and clearance rate as independent predictors of vasospasm after aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-010-9429-Z

Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-010-9429-Z

Does intracisternal thrombolysis prevent vasospasm after aneurysmal subarachnoid hemorrhage? A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-010-9429-Z

Intraventricular hemorrhage: severity factor and treatment target in spontaneous intracerebral hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-010-9429-Z

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-010-9429-Z

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-010-9429-Z

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-010-9429-Z

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-010-9429-Z

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-010-9429-Z

A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-010-9429-Z

Effect on cerebral vasospasm of coil embolization followed by microcatheter intrathecal urokinase infusion into the cisterna magna: a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-010-9429-Z

A multimodal concept in patients after severe aneurysmal subarachnoid hemorrhage: results of a controlled single centre prospective randomized multimodal phase I/II trial on cerebral vasospasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-010-9429-Z

Comparison of intrathecal administration of urokinase and tissue plasminogen activator on subarachnoid clot and chronic vasospasm in a primate model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-010-9429-Z

Phase I trial of tissue plasminogen activator for the prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-010-9429-Z

Cohort study of intraventricular thrombolysis with recombinant tissue plasminogen activator for aneurysmal intraventricular hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-010-9429-Z

Intraventricular hemorrhage after aneurysmal subarachnoid hemorrhage: pilot study of treatment with intraventricular tissue plasminogen activator.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-010-9429-Z

Intraventricular tissue plasminogen activator for the prevention of vasospasm and hydrocephalus after aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-010-9429-Z

Marked reduction of cerebral vasospasm with lumbar drainage of cerebrospinal fluid after subarachnoid hemorrhage

21 January 2018

1 reference

12 December 2020

A phase II clinical trial of recombinant human tissue-type plasminogen activator against cerebral vasospasm after aneurysmal subarachnoid hemorrhage

1 reference

12 December 2020

Does blinding of readers affect the results of meta-analyses? University of Pennsylvania Meta-analysis Blinding Study Group

1 reference

12 December 2020

The effect of timing of intrathecal fibrinolytic therapy on cerebral vasospasm in a primate model of subarachnoid hemorrhage.

1 reference

12 December 2020

Effect of intrathecal thrombolytic therapy on subarachnoid clot and chronic vasospasm in a primate model of SAH

1 reference

12 December 2020

[Combining exchange of cerebrospinal fluid with small dose of urokinase injection for subarachnoid hemorrhage]

1 reference

12 December 2020

Zhong nan da xue xue bao yi xue ban

20

30

217

YH Li

2005

1 reference

https://api.crossref.org/works/10.1007/S12028-010-9429-Z

23 June 2024

Identifiers

1 reference

23 August 2017

1 reference